Fundraising FoxLightstone Ventures — 2015 Investments
6 investments dated 2015 · listed companies and verified rows first · show all
FemTechHealthtechMedical DevicesRedwood City, US
Christopher Owens(Executive Officer, Director)Darrin Uecker(Executive Officer, Director)
BoardKen Haas(Director)Jonathan MacQuitty(Director)inDoug Fisher(Director)
Board seatMike Carusi· per SEC Form D
Co-investorsAmzak HealthBain Capital Life SciencesEndeavour VisionFemHealth VenturesKaiser Permanente VenturesKluz Ventures+6 more
Twelve transforms CO2 into chemicals, fuels, and materials through carbon transformation technology.
Advanced ManufacturingCleantechClimate TechHealthtechNew MaterialsMoses Lake, US
Nicholas Flanders(Founder)inEtosha Cave(Founder)inKendra Kuhl(Founder)inAndrew Cleeland(Executive Officer, Director)in
BoardMarc-Henri Galletti(Director)Nimesh Shah(Director)
Board seatHanson S. Gifford, IIIHenry A. Plain, Jr.· per SEC Form D
Co-investorsBreakout VenturesDCVC (Data Collective)Dolby Family VenturesFifth WallAdvantage Partners Inc.Aera VC+36 more
UCB (UCB SA/NV) is a publicly listed biopharmaceutical company focused on research and development of medicines for defined patient populations.
BiotechHealthtechCambridge, US
Douglas A. Treco(Executive Officer, Director)Kerry Black(Executive Officer)inJean-Christophe Tellier(Chief Executive Officer & Chairman of the Executive Committee)Sandrine Dufour(Executive Vice President, Chief Financial Officer)Jean Luc Fleurial(Executive Vice President, Chief Human Resources Officer)Fiona du Monceau(Executive Vice President, Chief Commercial Officer)
Co-investorsNew Enterprise Associates (NEA)RA CapitalMorgenthaler
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.